Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
Name:
37095186.pdf
Size:
527.5Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Evans, D GMcWilliams, L.
Astley, S.
Brentnall, A. R.
Cuzick, J.
Dobrashian, R.
Duffy, S. W.
Gorman, L. S.
Harkness, Elaine F
Harrison, F.
Harvie, Michelle N
Jerrison, A.
Machin, M.
Maxwell, Anthony J
Howell, Sacha J
Wright, S. J.
Payne, K.
Qureshi, N.
Ruane, H.
Southworth, J.
Fox, L.
Bowers, S.
Hutchinson, G.
Thorpe, E.
Ulph, F.
Woof, V.
Howell, Anthony
French, D. P.
Affiliation
NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, EnglandIssue Date
2023
Metadata
Show full item recordAbstract
NoneCitation
Gareth Evans D, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, et al. Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer. 2023 Apr 24. PubMed PMID: 37095186. Epub 2023/04/25. eng.Journal
British Journal of CancerDOI
10.1038/s41416-023-02273-3PubMed ID
37095186Additional Links
https://dx.doi.org/10.1038/s41416-023-02273-3Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41416-023-02273-3
Scopus Count
Collections
Related articles
- Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
- Authors: Gareth Evans D, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS, Harkness EF, Harrison F, Harvie M, Jerrison A, Machin M, Maxwell AJ, Howell SJ, Wright SJ, Payne K, Qureshi N, Ruane H, Southworth J, Fox L, Bowers S, Hutchinson G, Thorpe E, Ulph F, Woof V, Howell A, French DP
- Issue date: 2023 Jun
- Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
- Authors: Hawkins R, McWilliams L, Ulph F, Evans DG, French DP
- Issue date: 2022 Oct 12
- Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening.
- Authors: Houssami N, Zackrisson S, Blazek K, Hunter K, Bernardi D, Lång K, Hofvind S
- Issue date: 2021 May
- The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
- Authors: Saya S, Boyd L, Chondros P, McNamara M, King M, Milton S, Lourenco RA, Clark M, Fishman G, Marker J, Ostroff C, Allman R, Walter FM, Buchanan D, Winship I, McIntosh J, Macrae F, Jenkins M, Emery J
- Issue date: 2022 Sep 27
- Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial.
- Authors: Schneeweiss A, Möbus V, Tesch H, Hanusch C, Denkert C, Lübbe K, Huober J, Klare P, Kümmel S, Untch M, Kast K, Jackisch C, Thomalla J, Ingold-Heppner B, Blohmer JU, Rezai M, Frank M, Engels K, Rhiem K, Fasching PA, Nekljudova V, von Minckwitz G, Loibl S
- Issue date: 2019 Jan